5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.08▼ | 7.03▲ | 7.01▲ | 7.31▼ | 6.88▲ |
MA10 | 7.09▼ | 7.02▲ | 7.20▼ | 7.16▼ | 6.31▲ |
MA20 | 7.08▼ | 7.26▼ | 7.29▼ | 7.02▲ | 5.23▲ |
MA50 | 7.02▲ | 7.22▼ | 7.16▼ | 6.11▲ | 5.19▲ |
MA100 | 7.26▼ | 7.15▼ | 7.11▼ | 5.13▲ | 4.06▲ |
MA200 | 7.31▼ | 7.12▼ | 6.64▲ | 4.67▲ | 2.74▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | -0.028▼ | -0.060▼ | -0.029▼ | 0.265▲ |
RSI | 45.371▼ | 42.119▼ | 44.748▼ | 54.461▲ | 66.682▲ |
STOCH | 32.266 | 36.869 | 11.299▼ | 63.484 | 83.092▲ |
WILL %R | -94.737▼ | -83.140▼ | -86.574▼ | -59.119 | -23.383▲ |
CCI | -203.118▼ | -30.580 | -69.794 | 19.490 | 119.052▲ |
Friday, October 17, 2025 07:30 AM
Trial is evaluating ciforadenant as a potential first line therapy for metastatic renal cell cancer (RCC) in combination with ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1) Interim data shows ...
|
Thursday, October 16, 2025 06:56 PM
CVS Health Corporation (NYSE:CVS) is included among the 12 Must-Buy Dividend Stocks to Invest in. CVS Health Corporation (NYSE:CVS) stands among the largest pharmacy and retail chains in the United ...
|
Wednesday, October 15, 2025 11:02 PM
CVS Health Corporation (NYSE:CVS) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. CVS Health Corporation (NYSE:CVS), an American multinational healthcare company, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/10/25 | 7.52 | 7.70 | 6.90 | 7.04 | 989,990 |
16/10/25 | 7.89 | 7.98 | 7.35 | 7.65 | 1,401,784 |
15/10/25 | 7.13 | 7.72 | 6.84 | 7.69 | 2,162,776 |
14/10/25 | 6.90 | 7.25 | 6.81 | 7.04 | 986,334 |
13/10/25 | 7.27 | 7.51 | 7.03 | 7.11 | 1,079,122 |
10/10/25 | 7.24 | 7.29 | 6.78 | 6.93 | 837,217 |
09/10/25 | 6.98 | 7.2851 | 6.90 | 7.25 | 895,659 |
08/10/25 | 6.88 | 7.10 | 6.39 | 7.00 | 1,537,315 |
07/10/25 | 7.05 | 7.08 | 6.65 | 6.87 | 957,498 |
06/10/25 | 7.13 | 7.37 | 6.95 | 6.98 | 797,795 |
|
|
||||
|
|
||||
|
|